Clinical Data Requirements Under MDR: A Panel Discussion

NAMSA invites you to join us for an interactive panel discussion on clinical data requirements and challenges under MDR, led by our in-house regulatory experts. Even with the extended MDR transition period for legacy devices, it’s crucial to have a strong clinical data plan for all devices. We’ll begin by addressing common clinical data challenges manufacturers face under MDR, drawing from our experience with clients and notified bodies. Then, we’ll dive into an interactive panel discussion.

Attendees will gain insights into:

Clinical Evaluation Report (CER) requirements
Defining adequate clinical evidence
Evaluating clinical benefits
Strategies for Post-Market Follow-Up (PMCF)
Expectations of Notified Bodies regarding clinical data

Let’s Talk About Your Project

Ask a question or request a meeting with a NAMSA expert to discuss your specific project. We will follow up as quickly as possible. Also, please tell us how you heard about NAMSA.

First Name*

Last Name/Surname*

Business Email*

Company*

Where are you based?*

State*

How can we help?

By choosing to submit your information to contact NAMSA, you are providing NAMSA consent to process and store your information on the NAMSA Network. At any time, you can submit a request to withdraw your consent for the use of information provided by you. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.

Clinical Data Requirements Under MDR: A Panel Discussion

Published:

Content Type:

Attendees will gain insights into:

Let’s Talk About Your Project